advertisement

---

Tanaka Y 1

Showing records 1 to 1 | Display all abstracts from Tanaka Y

82739 Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
Aihara M; Lu F; Kawata H; Tanaka Y; Yamamura K; Odani-Kawabata N; Shams NK
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 542-550

---